The Warsaw office of Noerr has advised PFR Life Science, a subsidiary of the Polish Development Fund, which supports infrastructure and advanced technology projects, on its PLN 38.3 million investment in Mabion S.A., a biotechnology company in Poland. Mabion was represented by White & Case.
The EBRD also invested PLN 61.4 million.
The transaction consisted of a private placement through a sale of shares by Mabion’s majority shareholder, Twiti Investments Ltd., directed at institutional investors specializing in the health and biotechnology sector. All of the proceeds will be immediately lent to Mabion and repaid through the issuance of new shares to Twiti subject to the approval of a capital increase at Mabion’s extraordinary general meeting, which will be held in April 2018.
Noerr’s team included Pertners Ludomir Biedecki and Jakub Lerner and Associates Wojciech Nowosad and Marek Solarski.
White & Case lawyers from Warsaw, London, and New York advised Mabion.